Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors-Reference-Cited by-同舟云学术

Analysis of cerebrospinal fluid metabolites in patients with primary or metastatic central nervous system tumors

Published:2018-08-31 Issue:1 Volume:6 Page:
ISSN:2051-5960
Container-title:Acta Neuropathologica Communications
language:en
Short-container-title:acta neuropathol commun

Author:

Ballester Leomar Y.^ORCID,Lu Guangrong,Zorofchian Soheil,Vantaku Venkatrao,Putluri Vasanta,Yan Yuanqing,Arevalo Octavio,Zhu Ping,Riascos Roy F.,Sreekumar Arun,Esquenazi Yoshua,Putluri Nagireddy,Zhu Jay-Jiguang

Funder

National Institutes of Health

CIPRIT

American Cancer Society

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Clinical Neurology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1186/s40478-018-0588-z.pdf

Reference23 articles.

1. Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing 57:289–300. https://doi.org/10.2307/2346101

2. Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, Antonarakis ES, Azad NS, Bardelli A, Brem H, Cameron JL, Lee CC, Fecher LA, Gallia GL, Gibbs P, Le D, Giuntoli RL, Goggins M, Hogarty MD, Holdhoff M, Hong S-M, Jiao Y, Juhl HH, Kim JJ, Siravegna G, Laheru DA, Lauricella C, Lim M, Lipson EJ, Marie SKN, Netto GJ, Oliner KS, Olivi A, Olsson L, Riggins GJ, Sartore-Bianchi A, Schmidt K, Shih L-M, Oba-Shinjo SM, Siena S, Theodorescu D, Tie J, Harkins TT, Veronese S, Wang T-L, Weingart JD, Wolfgang CL, Wood LD, Xing D, Hruban RH, Wu J, Allen PJ, Schmidt CM, Choti MA, Velculescu VE, Kinzler KW, Vogelstein B, Papadopoulos N, Diaz LA (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6:224ra24–224ra24. https://doi.org/10.1126/scitranslmed.3007094

3. Chen Y, Ma Z, Min L, Li H, Wang B, Zhong J, Dai L (2015) Biomarker identification and pathway analysis by serum metabolomics of lung cancer. Biomed Res Int 2015:183624–183629. https://doi.org/10.1155/2015/183624

4. Chinnaiyan P, Kensicki E, Bloom G, Prabhu A, Sarcar B, Kahali S, Eschrich S, Qu X, Forsyth P, Gillies R (2012) The Metabolomic signature of malignant Glioma reflects accelerated anabolic metabolism. Cancer Res 72:5878–5888. https://doi.org/10.1158/0008-5472.CAN-12-1572-T

5. Dang L, White DW, Gross S, Bennett BD, Bittinger MA, Driggers EM, Fantin VR, Jang HG, Jin S, Keenan MC, Marks KM, Prins RM, Ward PS, Yen KE, Liau LM, Rabinowitz JD, Cantley LC, Thompson CB, Vander Heiden MG, Su SM (2009) Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature 462:739–744. https://doi.org/10.1038/nature08617

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomic profile of cerebrospinal fluid from patients with diffuse gliomas;Journal of Neurology;2024-09-03

2. Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges;International Journal of Molecular Sciences;2024-07-21

3. Biomarkers in Cerebrospinal Fluid for the Diagnosis and Monitoring of Gliomas;Biomolecules;2024-07-05

4. Advancements in Cerebrospinal Fluid Biosensors: Bridging the Gap from Early Diagnosis to the Detection of Rare Diseases;Sensors;2024-05-22

5. IDH inhibition in gliomas: from preclinical models to clinical trials;Nature Reviews Neurology;2024-05-17